When Two Clocks Run Down Together: Dysphagia at the Intersection of Aging and Neurodegenerative Disease

Apoorva T. Ramaswamy, MD, on behalf of the Airway and Swallowing Committee

Few clinical pictures in otolaryngology are as humbling as the patient with longstanding Parkinson disease who arrives with a third bout of aspiration pneumonia, or the spouse of a patient with Alzheimer disease asking whether mealtimes are going to be safe at home much longer. As the global population ages, the laryngologist’s clinic increasingly becomes a meeting point for two intersecting trajectories: the slow, predictable decline of presbyphagia, and the steeper, disease-specific decline imposed by neurodegeneration.

Aging is the single most influential risk factor for neurodegenerative disorders, with approximately one in 10 individuals aged 65 and older meeting criteria for dementia, the majority due to Alzheimer disease, with prevalence figures varying by diagnostic framework.^1,2,18,20 Normal age-related swallowing changes converge with neurologic impairment to produce a synergistic effect on swallow function.⁶ Two patients with the same severity of dementia can have radically different swallowing outcomes depending on what their baseline pharyngeal physiology looked like before disease arrived. Reserve, in this clinical space, is everything.

Presbyphagia: A Reduced-Reserve State

Presbyphagia refers to physiologic age-related changes in swallowing mechanics in the absence of functional impairment.⁷ It is a state of reduced reserve, not of failure. In one study of community-dwelling adults over 70, half demonstrated swallowing alterations on instrumental assessment despite being asymptomatic, mainly characterized by pharyngeal residue.⁸ Underlying changes include reduced pharyngeal sensation (the major clinical determinant of presbyphagia), sarcopenia of the swallowing musculature (accounting for roughly one-third of dysphagia in older adults), prolonged oral transit time, post-swallow aspiration, esophageal dysmotility, and decreased neuroplasticity that limits adaptive compensation.^6,7,8 Presbyphagia is itself an independent predictor of reduced nutritional status.⁸

The Demographics of Neurodegeneration

For adults aged 80 and older, the leading neurologic causes of disability are stroke, Alzheimer disease and other dementias, and Parkinson disease.^5,19 Stroke and cerebrovascular disease deserve special emphasis here: post-stroke cognitive impairment is common²² and the incidence of dementia after stroke or transient ischaemic attack is substantial.²³ Global Parkinson disease incident cases rose from approximately 450,000 in 1992 to 1.34 million in 2021, with projections approaching 1.93 million new cases per year by 2030, driven primarily by population aging.^4,5

When Aging Meets Neurodegenerative Disease

The combination of aging and neurodegenerative disease can transition a patient from compensated presbyphagia to overt dysphagia.^6,8 The mechanisms differ in instructive ways: aging alone produces prolonged oral transit and post-swallow aspiration, whereas neurodegenerative disease produces delayed pharyngeal swallow response and aspiration during the swallow itself, attributable to sensorineural impairment and disordered pharyngeal pressure dynamics on high-resolution manometry in Parkinson disease.^6,10,25 Aspiration during the swallow is generally more dangerous and harder to remediate than aspiration after the swallow.

Dysphagia affects 10-33% of community-dwelling older adults and more than 50% of nursing home residents.^8,16 In Parkinson disease, prevalence ranges from 11% to 81% depending on assessment method; subjective dysphagia is reported by 35% of patients, but objective testing reveals dysphagia in up to 82%.^9,24 This gap is a critical teaching point: a patient who denies trouble swallowing is not necessarily swallowing safely. Dysphagia prevalence in dementia is approximately 58% overall, with subtype variation (46.5% Alzheimer, 34.9% Parkinson dementia, 18.8% vascular).¹² In one case-control study, dysphagia was documented in 91.7% of elderly patients hospitalized with community-acquired pneumonia.^13,14,15

Clinical Implications

Dysphagia is now formally recognized as a geriatric syndrome because of its high prevalence and its association with malnutrition, aspiration pneumonia, frailty, institutionalization, readmission, and mortality.^6,16 Referrals for dysphagia in patients older than 60 years rose 64% between 2007 and 2014, and instrumental swallowing evaluation is becoming a core competency of laryngology rather than a subspecialty niche.⁷

Polypharmacy contributes substantial additional risk. Antipsychotics, benzodiazepines, anti-Parkinson drugs, antidepressants, antiepileptics, beta- and alpha-blockers, opioids, and anticholinergics have all been associated with aggravating or inducing dysphagia, even after adjusting for CNS disease.¹⁷ Medication review is therefore one of the highest-yield interventions in the dysphagia workup of an older adult.

Current best practice advocates for a neurogeriatric perspective recognizing disease-specific dysphagia manifestations while addressing presbyphagia, sarcopenia, and decreased neuroplasticity.⁶ Practically, this means screening earlier than symptoms would suggest. Brief tools like the EAT-10 or 3-ounce water swallow test should be standard for any older patient with a neurodegenerative diagnosis or unexplained weight loss. Instrumental swallow studies are essential, including FEES for sensory and bedside assessment and modified barium swallow for the pharyngeal phase in motion. Additional principles include treating sarcopenia as a modifiable variable through targeted swallowing rehabilitation and physical exercise (the evidence base for which continues to grow, particularly in Parkinson disease),¹¹ and engaging the caregiver as part of the treatment plan rather than an afterthought.

Active management combines behavioral, pharmacologic, and dietary strategies. On the behavioral side, expiratory muscle strength training (EMST) has the most robust randomized-trial evidence in Parkinson disease, with a four-week protocol shown to reduce overall dysphagia severity on FEES and to sustain that improvement at three months,²⁶ and structured exercise-based programs such as the McNeill Dysphagia Therapy Program have demonstrated functional gains across mixed neurologic and head and neck cancer populations.²⁷ Compensatory strategies, such as chin tuck, effortful swallow, supraglottic swallow, and bolus modification with thickened liquids or texture-modified diets should be selected based on the specific physiologic deficit identified on instrumental assessment rather than applied uniformly. Optimization of dopaminergic medication can improve swallowing in Parkinson disease, and timing meals to the patient’s "on" state is a simple but underused intervention.⁹ Finally, conversations about goals of care, the limited evidence for survival benefit from feeding tubes in advanced dementia, and patient preferences around comfort feeding belong in the laryngology visit, not deferred indefinitely to palliative care, because they shape every other recommendation we make.

Conclusion

The convergence of aging and neurodegenerative disease creates a vulnerable population in which physiologic reserve is depleted by both normal aging and disease-specific pathology, producing higher dysphagia prevalence and severity than either factor alone. The patients in front of us deserve a swallowing assessment that takes both clocks into account; the field of laryngology, in this era of demographic change, has the opportunity—and the obligation—to lead the integrated, neurogeriatric care this growing population requires.

References

1. Manly JJ, Jones RN, Langa KM, et al. Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project. JAMA Neurol. 2022;79(12):1242–1249. doi:10.1001/jamaneurol.2022.3543.
2. Jeste DV, Lieberman JA, Fassler D, et al. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2022.
3. Licher S, Darweesh SKL, Wolters FJ, et al. Lifetime risk of common neurological diseases in the elderly population. J Neurol Neurosurg Psychiatry. 2019;90(2):148–156. doi:10.1136/jnnp-2018-318650.
4. Xu L, Wang Z, Li Q. Global trends and projections of Parkinson’s disease incidence: a 30-year analysis using GBD 2021 data. J Neurol. 2025;272(4):286. doi:10.1007/s00415-025-13030-2.
5. Yang R, Sun M, Chen W, et al. Global, regional and national burden of Parkinson’s disease, 1990–2021: update from the GBD 2021 study. J Neurol Sci. 2025;480:125703. doi:10.1016/j.jns.2025.125703.
6. Thiyagalingam S, Kulinski AE, Thorsteinsdottir B, Shindelar KL, Takahashi PY. Dysphagia in older adults. Mayo Clin Proc. 2021;96(2):488–497. doi:10.1016/j.mayocp.2020.08.001.
7. Yadlapati RH, Shaheen NJ. Gastro-esophageal disorders of the geriatric population. Am J Gastroenterol. 2025;120(Suppl 10):S34–S44. doi:10.14309/ajg.0000000000003641.05.
8. Doan TN, Ho WC, Wang LH, et al. Prevalence and methods for assessment of oropharyngeal dysphagia in older adults: a systematic review and meta-analysis. J Clin Med. 2022;11(9):2605. doi:10.3390/jcm11092605.
9. Takizawa C, Gemmell E, Kenworthy J, Speyer R. A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson’s disease, Alzheimer’s disease, head injury, and pneumonia. Dysphagia. 2016;31(3):434–441. doi:10.1007/s00455-016-9695-9.
10. Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14(6):625–639. doi:10.1016/S1474-4422(15)00007-1.
11. Battel I, Arienti C, Del Furia MJ, et al. Rehabilitation interventions for oropharyngeal dysphagia in people with Parkinson’s disease. Cochrane Database Syst Rev. 2026;1:CD015816. doi:10.1002/14651858.CD015816.pub2.
12. Putri AR, Chu YH, Chen R, et al. Prevalence of swallowing disorder in different dementia subtypes among older adults: a meta-analysis. Age Ageing. 2024;53(3):afae037. doi:10.1093/ageing/afae037.
13. Almirall J, Rofes L, Serra-Prat M, et al. Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly. Eur Respir J. 2013;41(4):923–928. doi:10.1183/09031936.00019012.
14. Melgaard D, Baandrup U, Bøgsted M, Bendtsen MD, Hansen T. The prevalence of oropharyngeal dysphagia in Danish patients hospitalised with community-acquired pneumonia. Dysphagia. 2017;32(3):383–392. doi:10.1007/s00455-016-9765-z.
15. Cabre M, Serra-Prat M, Palomera E, et al. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing. 2010;39(1):39–45. doi:10.1093/ageing/afp100.
16. Leder SB, Suiter DM, Agogo GO, Cooney LM. An epidemiologic study on ageing and dysphagia in the acute care geriatric-hospitalized population: a replication and continuation study. Dysphagia. 2016;31(5):619–625. doi:10.1007/s00455-016-9714-x.
17. Wolf U, Eckert S, Walter G, et al. Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs. Sci Rep. 2021;11(1):21955. doi:10.1038/s41598-021-99858-w.
18. Jack CR, Therneau TM, Weigand SD, et al. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging–Alzheimer’s Association Research Framework. JAMA Neurol. 2019;76(10):1174–1183. doi:10.1001/jamaneurol.2019.1971.
19. Xiaopeng Z, Jing Y, Xia L, et al. Global burden of Alzheimer’s disease and other dementias in adults aged 65 years and older, 1991–2021: population-based study. Front Public Health. 2025;13:1585711. doi:10.3389/fpubh.2025.1585711.
20. Frisoni GB, Hansson O, Nichols E, et al. New landscape of the diagnosis of Alzheimer’s disease. Lancet. 2025;406(10510):1389–1407. doi:10.1016/S0140-6736(25)01294-2.
21. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 2007;6(12):1106–1114. doi:10.1016/S1474-4422(07)70291-0.
22. El Husseini N, Katzan IL, Rost NS, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2023;54(6):e272–e291. doi:10.1161/STR.0000000000000430.
23. Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248–258. doi:10.1016/S1474-4422(18)30442-3.
24. Gong S, Gao Y, Liu J, et al. The prevalence and associated factors of dysphagia in Parkinson’s disease: a systematic review and meta-analysis. Front Neurol. 2022;13:1000527. doi:10.3389/fneur.2022.1000527.
25. Szczesniak MM, Omari TI, Lam TY, et al. Evaluation of oropharyngeal deglutitive pressure dynamics in patients with Parkinson’s disease. Am J Physiol Gastrointest Liver Physiol. 2022;322(4):G421–G430. doi:10.1152/ajpgi.00314.2021.
26. Claus I, Muhle P, Suttrup J, et al. Expiratory muscle strength training for therapy of pharyngeal dysphagia in Parkinson’s disease. Mov Disord. 2021;36(8):1815–1824. doi:10.1002/mds.28552.
27. Crary MA, Carnaby GD, LaGorio LA, Carvajal PJ. Functional and physiological outcomes from an exercise-based dysphagia therapy: a pilot investigation of the McNeill Dysphagia Therapy Program. Arch Phys Med Rehabil. 2012;93(7):1173–1178. doi:10.1016/j.apmr.2011.11.008.